AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE in Zimbabwe
4 products registered with MCAZ — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TENOFOVIR DISOPROXIL FUMURATE; EMITRICITABINE; EFAVIRENZ TABLET; ORAL | 2018/7.13/5574 | STRIDES ARCOLAB LTD | active | 31 Dec 2027 |
| EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL | 2010/7.13/4649 | MYLAN LABORATORIES LIMITED | active | 31 Dec 2027 |
| EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE TABLET, COATED; ORAL | 2015/7.13/5051 | AUROBINDO PHARMA LIMITED | active | 31 Dec 2027 |
| TRIVENZ TABLET; ORAL | 2016/7.13/5186 | ADCOCK INGRAM LIMITED | active | 31 Dec 2027 |
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE — MCAZ Registration Details
MCAZ (Zimbabwe) has 4 registered products containing EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE, of which 4 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.